Trial NCT00112749

View at ClinicalTrials.gov 
Org. Study IDs: CDR0000428460
Secondary IDs: UCLA-0410033-01

Last trial update was posted on 2020-07-31

MeSH Interventions

Infliximab

MeSH Conditions

Breast Neoplasms Fatigue

Other Conditions

Breast Cancer

Stopping Reasons

Recruitment stopped due to slow accrual and lack of evidence of need for further continuation of protocol in inpatient setting.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID